Aurinia Pharmaceuticals Inc. (NASDAQ:$AUPH) shares
Post# of 22706
![Avatar](/images/ProfileImages/984076804_464_129571309_0017.gif)
What Analysts Say About Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
Stock has got outperform rating from no analyst of Thomson Reuters whereas no analyst given hold rating to the stock. Analyst’s mean target price for the firm is $8.90 while analysts mean recommendation is 1.50.
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) announced that its Chief Executive Officer, Charles Rowland, will present a corporate overview of the Company at the 2016 BIO Investor Forum, taking place October 18-19 at the Westin St. Francis in San Francisco.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
![937206596_images.jpg](https://investorshangout.com/images/MYImages/937206596_images.jpg)